This past April 13, Bloomberg.com reported that Bayer was going to pay at least $100 million to settle about 500 lawsuits regarding injuries and death connected with the use of its Yasmin line of birth control which includes Yasmin and Yaz.
In the wake of the skewed media coverage regarding how and why birth control is somehow the panacea for all females.
It seems to me that since Barack Obama is the star of a 17-minute puff-piece about his presidency.
When professed atheists begin suggesting to Catholics in name only that it’s time for them to leave the Church, there is something really good happening in America.
Sometimes an event will literally rock the earth beneath me. One such incident came to my attention recently by way of Jill Stanek—the pro-life movement’s number one commentator.
For those whose lives are not affected by facts, Planned Parenthood’s new campaign may seem appealing.
Researchers at the Arizona State University have linked the hormone in Depo Provera to memory loss. The birth-control shot can act as an abortifacient as well as a contraceptive.
Advocates of abortion and birth control often speak of “empowering women” with unbiased and vital information about reproductive health, but their silence following the most recent warning from the Federal Drug Administration (FDA) calls into question the nature of their concern for women’s health.
We, the people, have once again been steamrolled by the Obama administration and Planned Parenthood.
It is always interesting to receive e-mail alerts from my friend Patrick J. Reilly, president and founder of The Cardinal Newman Society.
Crises abound in the world today whether they are in the streets of London, the hallways of Congress, or the state capitals that house men and women hell-bent on dictating behavioral norms for all of us.
The administration’s decision results from an Institute of Medicine recommendation less than a month ago that argued that the use of birth control would curtail the number of unwanted pregnancies and thus reduce the abortion rate.